Государственное регулирование рынка ценных бумаг ФСФР России: анализ основных показателей деятельности по защите прав инвесторов

In crossover use of TFTD with/without Bev and regorafenib, both agents showed similar efficacy in terms of the conventional parameters, but the differences observed in the TGR and TGK might suggest some influence of prior regorafenib treatment on the efficacy of subsequent TFTD therapy, and vice ver... View More